News, Money and Drugs for Tuesday, May 19, 2009 – Elton John Speaks at BIO!!!
May 19, 2009 at 8:28 pm EST | Tags: Celebrities & Entertainment, Failed Drugs, Financing, Investors, Legal, News, Patents
Yeah, that headline is not incorrect. Elton John of Crocodile Rock fame gave the keynote address at BIO. How about the guys and girls from IguanaBio giving the keynote?? Now that’s news (lasers, banana peels, flowers and anything else you want to throw at us not allowed).
[Pharmalive]The Quigley Corporation says its Board is exploring various options, including hiring an investment banker and exploring “strategic alternatives” such as selling its pharma unit. [PRNewswire]
Switzerland’s Santhera Pharmaceuticals’ Catena® (idebenone) fails in a Phase 3 Friedreich’s Ataxia trial. [Genetic Engineering & Biotechnology News]
More Biotech Parks? Let’s get some money for these pipetters people!!! Please!!! [FierceBiotech]
Patents running out for Japanese pharma companies. [Financial Times]
Women (or men if that’s your deal) – is your man just not listening to you? Sneak some oxytocin up their nose. [Science Daily]
Everybody wants to sue Wyeth over the high price of Protonix. [Philly]
Opsona Therapeutics gets an extra EUR 3.3M ($4.45M USD) from the Roche Venture Fund and Enterprise Ireland. [Nasdaq]
Elixir Pharmaceuticals announced a $12M financing led by MPM Capital, also says it has granted Novartis an option to acquire the entire company following successful completion of a Phase 2 study with its ghrelin antagonist. [Xconomy]
Finally, Patrick Swazye is not DEAD!!! [EW]
And that’s that…
Image from topnews
Related Posts
No related posts.




I heard he sang his new song “Tiny Cancer”